SCHEMBL19786355

SCHEMBL19786355

c1ccc(-n2c3ccccc3c3c4c5ccc6ccccc6c5n(-c5ccccc5)c4c4ccc(-c5cccc6cc(-c7ccccn7)ccc56)cc4c32)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
TP53 P04637 2/20 0.35
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HSD17B10 Q99714 2/20 0.35
NPC1 O15118 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
GRM5 P41594 5/20 0.34
MAPK14 Q16539 1/20 0.34
HTR2C P28335 1/20 0.34
MCL1 Q07820 2/20 0.34
DCTPP1 Q9H773 1/20 0.32
TGFBR1 P36897 1/20 0.32
IRAK4 Q9NWZ3 1/20 0.32
LMNA P02545 1/20 0.31
PKM P14618 1/20 0.31
TSHR P16473 1/20 0.31
KLF5 Q13887 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21431925 0.85 BCHE (0.35) KDM4EALDH1A1TP53MAPTSMN1; SMN2
SCHEMBL19786304 0.81 MCL1 (0.36) KDM4ETP53SMN1; SMN2MAPK1MCL1
SCHEMBL19786615 0.81 KDM4E (0.40) KDM4EALDH1A1MAPK14LMNAFLT3
SCHEMBL19786669 0.78 GRM5 (0.39) KDM4ETP53MAPTSMN1; SMN2NPC1
SCHEMBL19786513 0.76 KDM4E (0.47) KDM4EALDH1A1MAPTHSD17B10HPGD
SCHEMBL9887467 0.75 GRM5 (0.38) KDM4EALDH1A1TP53MAPTSMN1; SMN2
SCHEMBL17071183 0.75 MAPT (0.37) KDM4EALDH1A1TP53MAPTSMN1; SMN2
SCHEMBL21432048 0.75 KDM4E (0.36) KDM4EALDH1A1TP53MAPTSMN1; SMN2
SCHEMBL15074012 0.75 L3MBTL1 (0.41) KDM4EALDH1A1MAPTMAPK14MCL1
SCHEMBL19786622 0.74 L3MBTL1 (0.34) KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-10-03 US disclosed
WO-2018012781-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF ORC3, OR51E2, ORAI2 KDM4E 442/4885ALDH1A1 2141/4885TP53 3473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.